Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis

No Thumbnail Available

Authors

Chan, J. K.
Herzog, T. J.
Hu, L.
Monk, B. J.
Kiet, T.
Blansit, K.
Kapp, D. S.
Yu, X.

Issue Date

2014

Type

Journal Article

Language

eng_US

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Chan, J. K., Herzog, T. J., Hu, L., Monk, B. J., Kiet, T., Blansit, K., Kapp, D. S., Yu, X. (2014). Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis. The Oncologist. 19(5), 523-527.

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/62254

PubMed ID

24721817

DOI

ISSN

1083-7159
1549-490X

EISSN

Collections

Faculty Bibliography Database